PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,990 stories, page 641 of 750

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Axsome starts 468-patient ADHD trial for teens

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Aethlon Medical tracks Ebola outbreak, readies Hemopurifier talks

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak

TMX NewsfileOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Mediterrania portfolio company Laprophan acquires Rivopharm

africaprivateequitynews.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Tryngolza charts blockbuster course after FDA’s hypertriglyceridemia approval

Pharmaceutical TechnologyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Quarterly Epidemiological Commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia and Clostridioides difficile infection, data up to January to March 2026

Epidemiological analyses of mandatory surveillance data on healthcare associated infections (HCAI);...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Hepatitis B: antenatal screening and selective neonatal immunisation pathway

Guidance on the delivery of antenatal screening and selective neonatal immunisation services for pre...

UK Health Security AgencyOriginal source
🌍Regulatoryinfarma.plTier 1 · Regulatory source

Każde 1 euro zainwestowane w nowe leki przynosi Europie 5,67 euro zwrotu.

INFARMA PolandOriginal source
🌍discoverynews.google.comTier 2 · Trade media

BIO 2026: Former FDA staff question agency’s “radical transparency” approach

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

San Diego Biopharma Begins First-in-Human Dosing of Obesity Drug as Phase 3 Catalysts Approach

Streetwise ReportsOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Intrathecal antibody test request form

Form E22 for requesting intrathecal antibody tests to be carried out by UK Health Security Agency's...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Consun Pharmaceutical Group Ltd. – HKEX:1681

TradingViewOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Polyomavirus JC investigation request form E13

Form (E13): polyomavirus investigation.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US biotech index hits record high, Danske Bank cites several drivers

medwatch.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Dizal (Jiangsu) Pharmaceutical Co. Ltd. Class A – SSE:688192

TradingViewOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Parvovirus B19 referral form

Form (E9): requesting serology and PCR tests.

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Varicella zoster virus referral form

Form (E11) for testing of varicella zoster virus.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Shandong Xinhua Pharmaceutical Company Limited Class H – LSX:A0M4YV

TradingViewOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

HHV-6 and HHV-7 referral form

Form (E18): Human herpesvirus 6 (HHV-6) integration studies and human herpesvirus 7 (HHV-7) detectio...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CNX and Legacy set July US relaunch for Ethyol

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

2 nationwide recalls you’ll want to check today

Rolling OutOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Otsuka posts positive Phase IIIb data for novel ADHD therapy

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 2 · Trade media

How iBio aims to stand out in obesity by targeting ‘both sides of the equation’ for antibody discovery

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Debt to equity ratio of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Pharmaceutical Technology

Pharmaceutical TechnologyOriginal source
🇿🇦Researchsu.ac.zaTier 3 · Secondary coverage

Seven days of gambling could wipe out a year of national student funding

Stellenbosch UniversityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Explosion and fire at pharmaceutical facility in New York State

HazardExOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Long term debt to total assets ratio of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Debt to assets ratio of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech (KRYS) Rallies On Pipeline Optimism, Is The Stock Already Pricey?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Pharmagreen Biotech Inc. – OTC:PHBI

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA ratio of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Operating margin % of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Net margin % of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

UK BioTech Thalia Therapeutics raises €3.1 million and acquires Sanmirna Therapeutics

EU-StartupsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Internal EU document: Biotech Act has only limited impact

medwatch.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New ASPE Report Finds U.S. Revenue Fuels Disproportionate Share of Pharmaceutical R&D Incentives

NAVLIN DAILYOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Clostridioides difficile ribotyping network (CDRN) report

Trends in ribotypes of Clostridioides difficile (C. difficile) and research into the increased frequ...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

DHSC: business appointment rules advice, January to March 2026

Summaries of advice given under the business appointment rules to applicants at SCS2 and SCS1 level...

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Weekly all-cause mortality surveillance: week ending 28 June 2026

How the actual number of deaths in England compare with expected numbers for each week.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

“Women should be valued and protected in pregnancy” – Heartbeat weighs in on abortion pill case

Pregnancy Help NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Expired gear, missing records: 2 Mumbai, Thane blood centres shut over safety lapses

The Indian ExpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ProQR validates RNA editing platform and raises $59.2m

European Biotechnology MagazineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Assenagon Asset Management S.A. Decreases Stock Holdings in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GCP Breakdown at King’s College Hospital Just Clouded the Most Promising Parkinson’s Trial in Years

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Unapproved Retatrutide Use Challenges Clinicians

MedscapeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Teva Pharmaceutical Industries Limited Sponsored ADR – FWB:TEV

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Helus Shares Experience Studying Adjunctive Psychedelic For Major Depressive Disorder

Clinical LeaderOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RTW Biotech Invests $1.4 Million In Lycia Series D Financing

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

3 Clinical-Stage Biotech Stocks Worth Watching In Parkinson's Research

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Korea's chip fund makes first biotech bet, backing LigaChem with $323 million

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Korea's chip fund makes first biotech bet, backing LigaChem with $323 million

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FIRST AID: Biotech Act deal by Christmas?

EuractivOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cereno Scientific Reports EAP Analyses with CS1 in PAH: Majority of Completing Patients Achieved Stable or Improved Clinical Status over 12 Months

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lupin Gets Tentative US FDA Nod for Enzalutamide Tablets

WhalesbookOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lupin gets tentative US FDA approval for generic prostate cancer drug

Business StandardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What Does the FDA's Priority Review Mean for Savara's MOLBREEVI

Kavout | AIOriginal source